Mulmit

ACADIA PHARMACEUTICALS INCACADIA PHARMACEUTICALS INC

ACAD Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,071,505,000104,811,000391,000,0002.3
2024-12-31957,797,000230,794,000226,000,0001.36
2023-12-31726,437,000-73,379,000-61,000,000-0.37
2022-12-31517,235,000-223,596,000-214,000,000-1.34
2021-12-31484,145,000-170,439,000-168,000,000-1.05

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-06Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER14,292
2026-08-06Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER5,000
2026-08-06Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER9,292
2026-08-06Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER14,292
2026-08-05Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER5,849
2026-08-05Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER5,849
2026-08-05Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER5,849
2026-07-30Thompson Elizabeth H.Z.EVP, Head of Research & Dev16,508
2026-07-30Thompson Elizabeth H.Z.EVP, Head of Research & Dev50
2026-07-29Thompson Elizabeth H.Z.EVP, Head of Research & Dev32,272
2026-07-29Thompson Elizabeth H.Z.EVP, Head of Research & Dev32,272
2026-06-26Kihara JamesPRINCIPAL ACCOUNTING OFFICER11,421

8-K events

FiledItems
2026-08-04Results of operations · Financial statements and exhibits
2026-05-29Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-06Results of operations · Financial statements and exhibits
2026-05-01Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-03-05Officer or director change
2026-02-25Results of operations · Financial statements and exhibits
2026-01-13Results of operations · Regulation FD disclosure · Financial statements and exhibits
2025-11-05Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.